Time-restricted Feeding in MASLD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Time-restricted Feeding in MASLD — Stella

Home/Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD)/

View on ClinicalTrials.gov

Recruiting

Back to Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Germany

Department of Internal Medicine II, Saarland University Medical Center, Saarland University,, Homburg, Saarland

Key details

Sponsor

Universität des Saarlandes

Collaborators

M3 Research Center, Dr. Suchira Gallage, Center for Molecular Signaling, Prof. Dr. Daniela Yildiz

Enrollment target

~120 participants

Started

October 2025

Primary completion

May 2029

Age range

18 Years – 75 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.